Gradient
Denervation Technologies

A new approach to treat pulmonary hypertension

Our Vision

Gradient Denervation Technologies is developing a new way to treat pulmonary hypertension, a fatal condition that affects thousands of patients per year, worldwide.

The therapeutic approach developed by Gradient Denervation Technologies aims at reducing pulmonary vascular resistance and improving cardiovascular hemodynamics.

Our goal at Gradient is to develop a device completely optimised for this indication, providing homogenous and durable results.

Gradient Denervation Technologies is currently focusing on prototyping work following a successful seed financing round.

Want to know more about Gradient ?

Send us your message